Liquidia (LQDA) Liabilities and Shareholders Equity (2019 - 2026)

Liquidia (LQDA) recorded quarterly Liabilities and Shareholders Equity of $401.5 million in Q1 2026, up 22.44% quarter-over-quarter from $327.9 million in Q4 2025, and up 76.55% on a YoY basis from $227.4 million in Q1 2025.

Liquidia (LQDA) Liabilities and Shareholders Equity (2019 - 2026) Analysis & Trends

Liquidia's Liabilities and Shareholders Equity history runs 8 years deep, the most recent figure standing at $401.5 million for Q1 2026.

  • In Q1 2026, Liabilities and Shareholders Equity rose 76.55% year-over-year to $401.5 million; the TTM figure through Mar 2026 stood at $1.3 billion (up 42.22% YoY), while the FY2025 annual figure was $327.9 million, up 42.39% from the prior year.
  • Liabilities and Shareholders Equity was $401.5 million for Q1 2026 at Liquidia, up from $327.9 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $401.5 million in Q1 2026 to a low of $93.5 million in Q1 2022.
  • Historically, Liabilities and Shareholders Equity has averaged $195.5 million across 5 years, with a median of $177.4 million in 2024.
  • The sharpest annual moves came in 2023 and 2024: Liabilities and Shareholders Equity declined 15.79% in 2023, then soared 126.52% in 2024.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $129.2 million in 2022, then declined by 8.41% to $118.3 million in 2023, then surged by 94.63% to $230.3 million in 2024, then soared by 42.39% to $327.9 million in 2025, then increased by 22.44% to $401.5 million in 2026.
  • The last three Liabilities and Shareholders Equity figures came in at $401.5 million (Q1 2026), $327.9 million (Q4 2025), and $276.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Teva Pharmaceutical Industries 38.77 Bn 35.04 Bn 1.97 Bn 40.04 Bn
2 Zoetis 34.11 Bn 32.16 Bn 1.62 Bn 15.15 Bn
3 United Therapeutics 23.68 Bn 21.53 Bn 648.10 Mn 6.71 Bn
4 Aurora Cannabis 16.48 Bn 16.40 Bn 33.43 Mn 555.95 Mn
5 Neurocrine Biosciences 16.19 Bn 14.88 Bn 800.70 Mn 4.91 Bn
6 Elanco Animal Health 11.44 Bn 11.01 Bn 785.00 Mn 13.22 Bn
7 Alkermes 7.28 Bn 6.77 Bn -116.06 Mn 4.26 Bn
8 Lantheus Holdings 6.48 Bn 5.98 Bn 230.92 Mn 2.35 Bn
9 Hims & Hers Health 6.35 Bn 5.60 Bn 396.79 Mn 2.27 Bn
10 Liquidia 5.74 Bn 5.52 Bn 121.79 Mn 401.53 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 401.53 Mn
Dec 31, 2025 327.93 Mn
Sep 30, 2025 275.98 Mn
Jun 30, 2025 257.41 Mn
Mar 31, 2025 227.43 Mn
Dec 31, 2024 230.31 Mn
Sep 30, 2024 252.89 Mn
Jun 30, 2024 177.36 Mn
Mar 31, 2024 197.12 Mn
Dec 31, 2023 118.33 Mn
Sep 30, 2023 111.64 Mn
Jun 30, 2023 121.60 Mn
Mar 31, 2023 128.92 Mn
Dec 31, 2022 129.20 Mn
Sep 30, 2022 132.57 Mn
Jun 30, 2022 139.08 Mn
Mar 31, 2022 93.53 Mn
Dec 31, 2021 93.73 Mn
Sep 30, 2021 100.30 Mn
Jun 30, 2021 104.38 Mn